Assignee
TALLAC THERAPEUTICS INC
US·3 granted patents·6 pending applications·2 citations·filing 2019–2024
Top patents by PatentIndex Score
9 records- 0189US11795463B2Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·16 claims
- 0285US11920136B2Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·47 claims
- 0379US2024191242A1Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0478US2024287528A1Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0566US12351598B2Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their useTALLAC THERAPEUTICS INC·Filed 2021·Granted Jul 8, 2025·0 cites·44 claims
- 0664US2024382610A1Nectin-4 antibodies and conjugatesTALLAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0761US2024374746A1Sirp-alpha antibodies and conjugatesTALLAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0853US2023364255A1Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0948US2022096649A1Immunomodulating polynucleotide conjugates and methods of useTALLAC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →